'Serious complications' are more frequent in COVID-19 patients given convalescent plasma, study says, dashing hopes for the treatment
A large Canadian-led study has shown, for now, that not only are the antibodies of recovered COVID-19 patients ineffective when used to treat seriously ill patients - but that convalescent plasma can even be harmful in certain circumstances.
The serious complications include an increased risk of intubation. There was also an increased risk of death.
The research involving Ste-Justine Hospital physician Dr. Philippe Begin as a co-principal investigator was published Thursday in the journal Nature Medicine.
Convalescent plasma consists of the antibody-containing liquid portion of a recovered person’s blood. The hypothesis was that once transfused to a sick patient, the antibodies would help the patient’s immune system fight the disease.
When the complete results were analyzed it wasn’t the lack of the treatment’s benefits that surprised investigators since the preliminary results of the CONCOR-1 study were equally underwhelming and prompted trial coordinators to stop recruitment last winter.
But some in the scientific community were taken aback by convalescent plasma’s serious downside - an increased risk for the patients’ health.
“That's what changes everything because according to many, it wasn't even considered possible," Begin said, but “overall, in our study, there were statistically more adverse events in the plasma group than in the non-plasma group.”
As a result, the researchers are urging clinicians to be cautious about using convalescent plasma outside of a research protocol, especially when they don’t have information about the antibody content.
BETTER AND WORSE ANTIBODY PROFILES
The study enrolled 940 patients in 73 hospitals in Canada, the United States, and Brazil for the randomized, controlled study.
Researchers say they were able to demonstrate that the specific antibody profile of the convalescent plasma administered had much to do with the effects on the patients.
According to information released by Ste Justine Hospital, the effect was determined by two distinct functions: the ability to neutralize the virus by interfering with its ability to invade the cell, or the ability to harness the power of the immune system to attack infected cells.
It’s this second function that could explain the negative effect of some plasmas.
"We know that not all antibodies have the same ability to activate the immune system. If dysfunctional antibodies are transfused, they can take the place of the patient's own antibodies against the virus, and ultimately interfere with the natural immune response,” Begin explained in a release.
The worst plasma, Begin said, seems to have a lot of antibodies, but with the wrong function.
Patients who received plasma with an antibody profile described as “good” had a comparable risk of intubation and death to that of the control group.
However, patients who received an “unfavourable’ antibody profile ”had a higher mortality rate,” the hospital reported.
MORE STUDIES NEEDED
While this was Canada’s largest clinical trial on convalescent plasma and COVID-19, and its findings are consistent with other studies, it does not mean that the book is closed, said Begin.
Now that many people have recovered from COVID-19 and have also been doubly vaccinated, “the antibody profile is extremely good for both neutralization and immune activation function," he said.
So Begin said it’s still possible convalescent plasma could hold promise as a treatment, but different antibody profiles will have to be properly evaluated before they know for certain.
CTVNews.ca Top Stories
'A step forward': New screening criteria for sperm donors takes effect
Canadians looking to grow their families with the assistance of sperm or egg donations should soon have more options for donors as the federal health agency does away with longstanding restrictions criticized as discriminatory.
What is whooping cough and should Canadians be concerned as Europe declares outbreak?
There is currently a whooping cough epidemic in Europe, with 10 times as many cases compared to the previous two years. While an outbreak has not been declared nationwide in Canada, whooping cough is regularly detected in the country.
Ontario Provincial Police arrest 64 suspects in child sexual exploitation investigation
Ontario Provincial Police say 64 suspects are facing a combined 348 charges in connection with a series of child sexual exploitation investigations that spanned the province.
'Summer of discontent': Federal unions vow to fight new 3-day a week office mandate
Federal unions are launching legal challenges and encouraging public sector workers to file "tens of thousands" of grievances over the new mandate requiring federal workers to return to the office at least three days a week in the fall.
Pfizer agrees to settle more than 10K lawsuits over Zantac cancer risk: Bloomberg News
Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal.
Watch fighter jet pilots pummel fake enemy ship off coast of Philippines
The United States and Philippines held annual joint-training drills just off the Southeast Asian nation’s western coast on Wednesday. Military forces sunk a 'mock' enemy warship – the BRP Lake Caliraya, which was a decommissioned tanker made in China.
U.S. presidential candidate RFK Jr. had a brain worm, has recovered, campaign says
Independent U.S. presidential candidate Robert F. Kennedy Jr. had a parasite in his head more than a decade ago, but has fully recovered, his campaign said, after the New York Times reported about the ailment.
'Ozempic babies': Reports of surprise pregnancies raise new questions about weight loss drugs
Numerous women have shared stories of 'Ozempic babies' on social media. But the joy some experience in discovering pregnancies may come with anxiety about the unknowns.
Rookie goalie Arturs Silovs to start for Canucks in Game 1 vs. Oilers
Rookie goalie Arturs Silovs will start in net for the Canucks as Vancouver kicks off a second-round series against the Edmonton Oilers Wednesday night.